TCIM
ANIP icon

TIAA CREF Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

TIAA CREF Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.46M Buy
48,997
+1,290
+3% +$75.9K ﹤0.01% 1674
2018
Q4 		$2.15M Sell
47,707
-960
-2% -$50.3K ﹤0.01% 1915
2018
Q3 		$2.75M Buy
48,667
+2,635
+6% +$161K ﹤0.01% 1956
2018
Q2 		$3.08M Buy
46,032
+2,050
+5% +$128K ﹤0.01% 1935
2018
Q1 		$2.56M Sell
43,982
-846
-2% -$53.7K ﹤0.01% 1980
2017
Q4 		$2.89M Buy
44,828
+4,543
+11% +$283K ﹤0.01% 1934
2017
Q3 		$2.12M Buy
40,285
+18,679
+86% +$891K ﹤0.01% 2138
2017
Q2 		$1.01M Sell
21,606
-71
-0.3% -$3.42K ﹤0.01% 2546
2017
Q1 		$1.07M Sell
21,677
-1,790
-8% -$101K ﹤0.01% 2477
2016
Q4 		$1.42M Sell
23,467
-1,359
-5% -$83.1K ﹤0.01% 2362
2016
Q3 		$1.65M Sell
24,826
-805
-3% -$50.4K ﹤0.01% 2277
2016
Q2 		$1.43M Buy
25,631
+659
+3% +$32K ﹤0.01% 2327
2016
Q1 		$841K Sell
24,972
-9,463
-27% -$321K ﹤0.01% 2573
2015
Q4 		$1.55M Sell
34,435
-1,603
-4% -$69K ﹤0.01% 2313
2015
Q3 		$1.42M Sell
36,038
-745
-2% -$42.4K ﹤0.01% 2354
2015
Q2 		$2.28M Buy
36,783
+3,438
+10% +$205K ﹤0.01% 2221
2015
Q1 		$2.09M Sell
33,345
-286
-0.9% -$17.4K ﹤0.01% 2195
2014
Q4 		$1.9M Sell
33,631
-1,803
-5% -$79.5K ﹤0.01% 2282
2014
Q3 		$1M Buy
35,434
+191
+0.5% +$5.72K ﹤0.01% 2622
2014
Q2 		$1.21M Buy
+35,243
New +$1.11M ﹤0.01% 2597

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TIAA CREF Investment Management's ANIP Position: Q1 2019 in Review

TIAA CREF Investment Management increased its ANI Pharmaceuticals (ANIP) stake by 2.7% in Q1 2019, buying an estimated $75.9K and bringing the position to 48,997 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #1674.

TIAA CREF Investment Management first reported a position in ANIP in Q2 2014 and has held it in 20 quarters since. 190 funds tracked by Wall St. Rank hold ANIP as of Q1 2019.

  • TIAA CREF Investment Management held 48,997 shares of ANI Pharmaceuticals worth $3.46M as of Q1 2019.
  • TIAA CREF Investment Management bought 1,290 ANI Pharmaceuticals shares in Q1 2019, an estimated $75.9K.
  • ANI Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1674 holding.
  • TIAA CREF Investment Management first reported a position in ANI Pharmaceuticals in Q2 2014 and has held it in 20 quarters since.
  • 190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.